Stay updated with breaking news from Overt Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What You Should Know: - OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing
OverT Bio has secured $16m in a seed funding round to expand its discovery platforms aimed at developing cellular therapies for solid tumours.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!